Developing a mouse model to study antibiotic-resistant gonorrhea
Task A100: Mouse Model of Neisseria Gonorrhoeae Antibiotic Resistant Infection
['FUNDING_OTHER'] · PHARMACOLOGY DISCOVERY SERVICES TAIWAN, LTD. · NIH-11178799
This study is working on developing better mouse models to understand gonorrhea infections, especially those that don't respond to antibiotics, so that we can find new treatments that could help people dealing with this tough health issue.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | PHARMACOLOGY DISCOVERY SERVICES TAIWAN, LTD. (nih funded) |
| Locations | 1 site (NEW TAIPEI CITY, TAIWAN) |
| Trial ID | NIH-11178799 on ClinicalTrials.gov |
What this research studies
This research focuses on creating and improving mouse models to better understand infections caused by Neisseria gonorrhoeae, particularly those that are resistant to antibiotics. By simulating these infections in mice, researchers aim to evaluate potential treatments and countermeasures against this growing public health threat. Patients may benefit from insights gained through this research, which could lead to more effective therapies for antibiotic-resistant gonorrhea.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have been diagnosed with gonorrhea, particularly those with antibiotic-resistant strains.
Not a fit: Patients who do not have gonorrhea or those with non-resistant strains may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new treatments for antibiotic-resistant gonorrhea, improving patient outcomes.
How similar studies have performed: Previous research has shown success in developing animal models for studying antibiotic resistance, indicating that this approach has potential.
Where this research is happening
NEW TAIPEI CITY, TAIWAN
- PHARMACOLOGY DISCOVERY SERVICES TAIWAN, LTD. — NEW TAIPEI CITY, TAIWAN (ACTIVE)
Researchers
- Principal investigator: MIESEL, LYNN — PHARMACOLOGY DISCOVERY SERVICES TAIWAN, LTD.
- Study coordinator: MIESEL, LYNN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.